The Genome Institute

A consortium of researchers led by the School of Medicine has identified virtually all of the major mutations that drive acute myeloid leukemia (AML), a fast-growing blood cancer in adults that often is difficult to treat. The dark lines in the image pictured show all of the major mutations for AML that occurred in one patient with the disease.

The most in-depth look yet at endometrial cancer shows that adding genomics-based testing to the standard diagnostic workup could change the recommended course of treatment for some women. The new research is published in the journal Nature. Pictured are endometrial cancer cells under a microscope.

Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer involving genes that are already being targeted for drug development.

St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project has announced the largest release to date of comprehensive human cancer genome data for free access by the global scientific community.

For the second consecutive year, Richard Wilson, PhD, director of Washington University’s Genome Institute, was named as one of the world’s most-cited scientific authors, according to Thomson Reuters Science Watch. The annual survey tracks research across various scientific disciplines to determine which papers published in the past two years were cited most often by other […]

Undergraduate students were in St. Louis Nov. 9-12 for the Annual Biomedical Research Conference for Minority Students, designed to encourage undergraduate, post baccalaureate and graduate underrepresented minority students to pursue advanced training in the biomedical and behavioral sciences. Washington University, under the leadership of the Division of Biology and Biomedical Sciences, hosted a visit the Danforth and Medical campuses for about 200 students.

School of Medicine scientists, including Richard Wilson, PhD, have completed the largest analysis to date of the genetic mutations underlying ovarian cancer.